Compare

Flexible Solutions International Inc vs ASP Isotopes Inc. vs Arq, Inc. vs Pure Bioscience, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearFlexible Solutions International Inc
FSI
ASP Isotopes Inc.
ASPI
Arq, Inc.
ARQ
Pure Bioscience, Inc.
PURE
Year ended2025-12-312025-12-312025-12-312026-07-31
Revenue$38.52M$23.85M$120.34M$2.32M
Revenue growth (YoY)+0.7%+475.5%+10.4%+5.3%
Gross margin32.6%14.3%27.9% (computed)57.2%
Operating margin11.9%-251.2%-44.0%-89.9%
Net margin2.0%-670.2%-43.7%-107.1%
Net income$786.9K-$159.84M-$52.61M-$2.48M
EPS (Diluted)$0.06-$2.11-$1.27-$0.02
Operating cash flow$3.78M-$37.78M-$2.73M-$1.74M
Free cash flow-$591.7K-$47.43M-$11.31Mn/a
Cash & equivalentsn/a$285.60M$6.57M$569.0K
Total assets$61.83M$498.02M$230.58M$1.19M
Total liabilities$19.00M$235.12M$62.62M$7.59M
Shareholders' equity$38.91M$204.15M$167.96M-$6.40M
Return on year-end equity2.0%-78.3%-31.3%n/a
Shares outstanding12.72M111.68M42.73M130.02M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearFlexible Solutions International IncASP Isotopes Inc.Arq, Inc.Pure Bioscience, Inc.
Latest$38.52M
Ended 2025-12-31
$23.85M
Ended 2025-12-31
$120.34M
Ended 2025-12-31
$2.32M
Ended 2026-07-31
1 year earlier$38.23M
Ended 2024-12-31
$4.14M
Ended 2024-12-31
$108.96M
Ended 2024-12-31
$2.20M
Ended 2025-07-31
2 years earlier$38.32M
Ended 2023-12-31
$433.0K
Ended 2023-12-31
$99.18M
Ended 2023-12-31
$1.96M
Ended 2024-07-31
3 years earlier$45.84M
Ended 2022-12-31
$0
Ended 2022-12-31
$102.99M
Ended 2022-12-31
$1.88M
Ended 2023-07-31
4 years earlier$34.42M
Ended 2021-12-31
n/a$100.29M
Ended 2021-12-31
$1.85M
Ended 2022-07-31